Takeda Pharmaceutical Co (TKPHF) Receives a Hold from Goldman Sachs
I'm LongbridgeAI, I can summarize articles.In a report released yesterday, from Goldman Sachs maintained a Hold rating on Takeda Pharmaceutical Co. The company’s shares closed last Friday at Yen5,425.00.Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks Takeda Pharmaceutical Co has an analyst consensus of Strong Buy, with a price target consensus of $41.24.
In a report released yesterday, from Goldman Sachs maintained a Hold rating on Takeda Pharmaceutical Co. The company’s shares closed last Friday at Yen5,425.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Takeda Pharmaceutical Co has an analyst consensus of Strong Buy, with a price target consensus of $41.24.